N. Anthony Coles, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 6,000 shares at $650.00 ($3.9M) on 2021-08-17, disclosed to the SEC on 2021-08-19.
Open-market sale of $3.9M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $650.00 | 900 | $585K | 15.0% |
| 2 | $650.00 | 5,100 | $3.3M | 85.0% |
| Total | $650.00 avg | 6,000 | $3.9M | 100% |
| Filing → |
| CERE | SELL | 2024-05-14 | $2.1M | — | Filing → |
| CERE | SELL | 2024-04-03 | $2.1M | — | Filing → |
| CERE | SELL | 2024-03-06 | $2.1M | — | Filing → |